HCM
IDXX icon

Hengehold Capital Management’s Idexx Laboratories IDXX Stock Holding History

Hengehold Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-315
Closed -$213K – 222
2025
Q4 		$213K Hold
315
– – 0.02% 212
2025
Q3 		$201K Buy
+315
New +$191K 0.02% 215
2022
Q1 		– Sell
-324
Closed -$213K – 172
2021
Q4 		$213K Sell
324
-5
-2% -$3.14K 0.03% 160
2021
Q3 		$205K Hold
329
– – 0.03% 155
2021
Q2 		$208K Buy
+329
New +$182K 0.03% 154

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hengehold Capital Management's IDXX Position: Q1 2026 in Review

Hengehold Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 315 shares — an estimated $213K sold.

Hengehold Capital Management first reported a position in IDXX in Q2 2021 and held it in 5 quarters. The position peaked at $213K in Q4 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Hengehold Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Hengehold Capital Management sold 315 Idexx Laboratories shares in Q1 2026, an estimated $213K.
  • Hengehold Capital Management first reported a position in Idexx Laboratories in Q2 2021 and held it in 5 quarters.
  • Hengehold Capital Management's Idexx Laboratories position peaked at $213K in Q4 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Hengehold Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.